✦ LIBER ✦

Clinical analysis of 19 patients with pleural mesothelioma

✍ Scribed by Jianming Dou; Pang Qingshu; Liu Dongxing

Publisher: Chinese Anti-Cancer Association
Year: 1999
Tongue: English
Weight: 162 KB
Volume: 11
Category: Article
ISSN: 1000-9604
DOI: 10.1007/bf02948460

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thrombocytosis in patients with malignan

Thrombocytosis in patients with malignant pleural mesothelioma

✍ Line Lisbeth Olesen; Henning Thorshauge 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 2 views

Platelet counts were studied retrospectively in a series of 64 patients suspected of primary malignant pleural mesothelioma. Only platelet counts taken before chemotherapy and radiotherapy and surgery other than thoracocentesis were considered. Thirty-two patients had malignant pleural mesothelioma

Cardiac abnormalities in patients with d

Cardiac abnormalities in patients with diffuse malignant pleural mesothelioma

✍ Scott Wadler; Dr. Philippe Chahinian; William Slater; Martin Goldman; David Mend 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 680 KB

Many patients with diffuse malignant pleural mesothelioma have dyspnea or chest pain. Cardiac symptomatology is frequently difficult to differentiate from symptoms of pleuropulmonary disease. To better define the clinical characteristics of cardiac involvement in patients with mesothelioma, the elec

Hyaluronan content in pleural fluid as a

Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma

✍ Anders Thylén; Anders Hjerpe; Gunnar Martensson 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

Erlotinib plus bevacizumab in previously

Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma

✍ David M. Jackman; Hedy L. Kindler; Beow Y. Yeap; Panos Fidias; Ravi Salgia; Joan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Gemcitabine and vinorelbine in pemetrexe

Gemcitabine and vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma

✍ Paolo A. Zucali; Giovanni L. Ceresoli; Isabella Garassino; Fabio De Vincenzo; Ra 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract ## BACKGROUND Pemetrexed‐cisplatin chemotherapy is the standard of care in the first‐line treatment of unresectable malignant pleural mesothelioma (MPM). Second‐line cytotoxic therapy is considered for a growing group of patients, but the optimal treatment has not been defined to date.

A phase II study of gemcitabine in patie

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo